HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Porsteinsson, A. P. Articles by Gaile, S. Search for Related Content PubMed PubMed Citation Articles by Porsteinsson, A. P. Articles by Gaile, S.

An Open Trial of Valproate for Agitation in Geriatric Neuropsychiatric Disorders

University of Rochester School of Medicine, Rochester, New York.

The authors assessed the efficacy, tolerability, and safety of open valproate administration in a group of elderly patients with agitation and neuropsychiatric disorders (N = 13), most of whom had dementia (n = 12). Dosing was individualized according to the response of target symptoms and side effects. Clinical Global Impression of Change (vs. baseline) measured efficacy. This open treatment suggested that valproate reduced agitated behaviors in some patients, and is well tolerated; thus, results warrant a larger, randomized, placebo-controlled study.

This article has been cited by other articles:

				A. T. Blaszczyk and M. Mathys Treatment of Cognitive Decline and Psychiatric Disturbances Associated With Alzheimer's Dementia Journal of Pharmacy Practice, February 1, 2007; 20(1): 13 - 28. [Abstract] [PDF]

				J. L. Cummings Alzheimer's Disease N. Engl. J. Med., July 1, 2004; 351(1): 56 - 67. [Full Text] [PDF]

				F. H. Ramadan, B. J. Naughton, and R. Prior Correlates of Behavioral Disturbances and Pattern of Psychotropic Medication Use in Five Skilled Nursing Facilities J Geriatr Psychiatry Neurol, March 1, 2003; 16(1): 8 - 14. [Abstract] [PDF]

				O. L. Lopez, J. T. Becker, R. A. Sweet, W. Klunk, D. I. Kaufer, J. Saxton, and S. T. DeKosky Patterns of Change in the Treatment of Psychiatric Symptoms in Patients With Probable Alzheimer's Disease From 1983 to 2000 J Neuropsychiatry Clin Neurosci, February 1, 2003; 15(1): 67 - 73. [Abstract] [Full Text] [PDF]

				W. T. Regenold and M. Prasad Uses of Intravenous Valproate in Geriatric Psychiatry Am J Geriatr Psychiatry, August 1, 2001; 9(3): 306 - 308. [Abstract] [Full Text] [PDF]

				A. P. Porsteinsson, P. N. Tariot, R. Erb, C. Cox, E. Smith, L. Jakimovich, J. Noviasky, N. Kowalski, C. J. Holt, and C. Irvine Placebo-Controlled Study of Divalproex Sodium for Agitation in Dementia Am J Geriatr Psychiatry, February 1, 2001; 9(1): 58 - 66. [Abstract] [Full Text]

				M. Gardner, L. Ditmanson, R. W Garrett, T. Luu, and F. Meiling Anticonvulsant Use in Treating Dementia-Related Agitation Journal of Pharmacy Practice, August 1, 2000; 13(4): 308 - 315. [Abstract] [PDF]

				P. E. Chatham Showalter and D. N. Kimmel Agitated Symptom Response to Divalproex Following Acute Brain Injury J Neuropsychiatry Clin Neurosci, August 1, 2000; 12(3): 395 - 397. [Abstract] [Full Text]

				O. L. Lopez, S. R. Wisniewski, J. T. Becker, F. Boller, and S. T. DeKosky Psychiatric Medication and Abnormal Behavior as Predictors of Progression in Probable Alzheimer Disease Arch Neurol, October 1, 1999; 56(10): 1266 - 1272. [Abstract] [Full Text] [PDF]